3,4-Methylenedioxy-N-hydroxyamphetamine

From WikiMD's Medical Encyclopedia

Revision as of 22:09, 16 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Chemical compound


3,4-Methylenedioxy-N-hydroxyamphetamine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 74698-46-5
PubChem 4433
DrugBank
ChemSpider 4278
KEGG


3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH) is a chemical compound that belongs to the class of substituted amphetamines. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known psychoactive substances.

Chemical Structure[edit]

MDOH is characterized by the presence of a methylenedioxy group attached to the phenyl ring and an N-hydroxy group attached to the amphetamine backbone. The chemical formula for MDOH is C10H13NO3.

Pharmacology[edit]

MDOH is known to act as a serotonin releasing agent, similar to its analogs MDA and MDMA. It affects the central nervous system by increasing the release of serotonin, which can lead to altered mood and perception.

Effects[edit]

The effects of MDOH are not as well-documented as those of MDMA or MDA. However, it is believed to produce entactogenic effects, which are characterized by feelings of emotional closeness and empathy. The psychoactive effects are likely to be similar to those of other empathogens.

Legal Status[edit]

The legal status of MDOH varies by country. In many jurisdictions, it is considered a controlled substance due to its structural similarity to MDMA and MDA, which are both classified as illegal drugs.

Synthesis[edit]

The synthesis of MDOH involves the introduction of an N-hydroxy group to the amphetamine structure. This can be achieved through various chemical reactions, often starting from precursor compounds such as safrole or isosafrole.

Related Compounds[edit]

See Also[edit]

Related pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.